- 【Oral Presentation 1】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 09:00 - 10:30 | Oral Presentation |
- 【Oral Presentation 2】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 10:30 - 12:00 | Oral Presentation |
- 【Luncheon Symposium 1】Sponsored by：Bayer
- Chair：Chih-Ching Lin
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | One Move Can Change the Outcome : nsMRAs as a Novel Pillar in DKD Treatment |
Shang-Feng Tsai
|
- 【Award Session】Excellent Research Award Speech (Young Investigator Award and Outstanding Research Paper Award)
- Chair：Chih-Ching Lin、Bang-Gee Hsu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 14:15 | Uremic Sarcopenia: from Clinical Research to Patient Care |
Yu-Li Lin
|
||
| 14:15 - 14:45 | Circulating Activin A: A Potential Biomarker for Kidney Fibrosis and Poor Renal Outcomes |
Ming-Tsun Tsai
|
||
| 14:45 - 15:00 | Discussion |
- 【Symposium 2】Integrating Toxicological Science to Elucidate the Gut-Kidney Axis: A Dual Framework for Food Safety and Renal Protection
- Chair：Chih-Kang Chiang、Ming-Ju Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 15:15 - 15:45 | Introduction to Toxicology and Its Applications in Food Safety |
Chia-Ter Chao
|
||
| 15:45 - 16:15 | Risk of Food Safety and Kidney Health: Case Analysis of the Polam Kopitiam Incident and Red Yeast Contamination in Japan |
Jia-Huang Chen
|
||
| 16:15 - 16:45 | Gut Microbiota and Kidney Disease |
Chih-Chao Yang
|
||
| 16:45 - 17:00 | Discussion |
- 【Oral Presentation 3】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 09:00 - 10:30 | Oral Presentation |
- 【Symposium 1】What is New in AKI CRRT
- Chair：Vin-Cent Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 10:30 - 10:35 | Opening |
Yung-Chang Chen
|
||
| 10:30 - 11:20 | The Updated of AKI Advance |
Neesh Pannu
|
||
| 11:20 - 11:32 | CVVHD with RCA: What is the Evidence? |
Tao-Min Huang
|
||
| 11:32 - 11:44 | Regional Citrate Anticoagulation: Complications and Solutions in CRRT Practice |
Cheng-Chia Lee
|
||
| 11:44 - 11:56 | Outcome of Regional Citrate |
Guan Hong Lin
|
||
| 11:56 - 12:00 | Closing |
Yen-Ta Huang
|
- 【Luncheon Symposium 2】Sponsored by：Boehringer Ingelheim
- Chair：Mai-Szu Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | GLT2 Inhibitors in Chronic Kidney Disease: A New Frontier?" - Discuss emerging evidence for the use of SGLT2 inhibitors in CKD patients and impact on reducing the risk of chronic kidney disease progression |
Chih-Chao Yang
|
- 【Symposium 3】2024 TSS & TSN Treatment Guidelines for Stroke Patients with Chronic Kidney Disease
- Chair：Yung-Ho Hsu、Lung Chan
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 13:35 | Opening | |||
| 13:35 - 14:00 | Management of Ischemic Stroke in Patients with CKD |
Yu-Ming Chang
|
||
| 14:00 - 14:25 | Dialyzing a Patient with Acute Stroke: What a Nephrologist Needs to Know |
Tao-Min Huang
|
||
| 14:25 - 14:50 | Management of Hemorrhagic Stroke in Patients with CKD |
Hung-Yu Huang
|
||
| 14:50 - 15:15 | Primary and Secondary Prevention of Stroke in Patients with CKD |
Jia-Jung Lee
|
||
| 15:15 - 15:20 | Discussion |
- 【Symposium 4】Chronic Kidney Disease and Kidney Aging
- Chair：Reiko Inag, Huang-Yu Yang
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 15:45 - 15:50 | Opening | |||
| 15:50 - 16:10 | Dialysis outcomes in the Older Age group – NZ experience |
Robert Walker
|
||
| 16:10 - 16:30 | Organelle stress and organelle communication |
Reiko Inagi
|
||
| 16:30 - 16:50 | Uremia-Associated Immunosenescence and Clinical Outcomes in Patients with CKD |
Ting-Yun Lin
|
||
| 16:50 - 17:10 | Roles of Advanced Glycation End Products (AGEs) and Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) in Age-related Chronic Kidney Disease |
Chih-Kang Chiang
|
||
| 17:10 - 17:20 | Discussion |
- 【Oral Presentation 4】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 09:00 - 10:30 | Oral Presentation |
- 【Industry Symposium I】Sponsored by：Novo Nordisk Taiwan
- Chair：Der-Cherng Tarng
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 11:00 - 11:50 | GLP-1 RAs: New Possibilities for Managing CKD in People with Type 2 Diabetes |
Wei-Hung Lin
|
- 【Luncheon Symposium 3】Sponsored by：Fresenius Kabi Taiwan Ltd.
- Chair：Ming-Ju Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | How Can Keto-analogues Help in The New Era of CKD Therapy |
Ming-Ju Wu
|
- 【Outstanding Academic Research Meeting I】Translating Metabolomics into Clinical Practice
- Chair： Chun-Liang Lin、Chih-Chien Sung
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 13:55 | Metabolomics in the Identification of Disease-Associated Metabolites and Therapeutic Targets: From Discovery to Clinical Translation |
Cheng-Chin Kuo
|
||
| 13:55 - 14:20 | Investigation of Energy Metabolism Pathways and Biomarkers Verification in Renal Cancer Through Integrated Proteomics and Metabolomics |
Yi-Ting Chen
|
||
| 14:20 - 14:45 | Metabolites from Thermogenic Adipocytes as Signaling Molecules in Glucose and Energy Metabolism Regulation |
Chih-Hao Wang
|
||
| 14:45 - 15:00 | Panel Discussion |
- 【Outstanding Academic Research Meeting II】Pathological Mechanisms and Therapeutic Opportunities from an Interdisciplinary Perspective: From Basic Research to Clinical Application
- Chair：Junne-Ming Sung、Horng-Yih Ou
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 15:15 - 15:40 | Exploring the Pathogenesis of GS and PHAII: from Animal to Clinical Study |
Chih-Chien Sung
|
||
| 15:40 - 16:05 | Collagen Fibril: A Friend or A Foe? |
Ming-Jer Tang
|
||
| 16:05 - 16:30 | Therapeutic Targeting of Common Pathway in Obesity and Type 2 Diabetes - The CCR5-Mediated Signaling |
Po-Shiuan Hsieh
|
||
| 16:30 - 16:55 | 臨床實務中的研究契機 |
Chih-Cheng Hsu
|
||
| 16:55 - 17:00 | Panel Discussion |
- 【Industry Symposium II】Sponsored by：AstraZeneca
- Chair：Horng-Rong Chang
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 11:00 - 11:50 | Revolutionizing the Standard of Care for aHUS Patients |
Hsin-Yu Chen
|
- 【Luncheon Symposium 4】Sponsored by：AstraZeneca
- Chair：Shang-Jyh Hwang
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | Optimizing SGLT2 Inhibitors and Hyperkalemia Management in Late-stage CKD |
Shang-Jyh Hwang
|
- 【ISN-TSN Joint Symposium】Advancing Research in Nephrology: A Global Perspective
- Chair：Mai-Szu Wu, Robert Walker, Chih-Wei Yang
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 13:35 | Opening Remark |
Mai-Szu Wu
|
||
| 13:30 - 13:45 | Clinical Research in Chronic Kidney Disease: Insights from ISN Perspective |
Robert Walker
|
||
| 13:45 - 14:00 | Considerations on Study Design and Protocol Development for Clinical Research in Nephrology |
Neesh Pannu
|
||
| 14:00 - 14:15 | Strengths and Pitfalls of Meta-analysis and Systematic Review in Nephrology Research |
Giovanni Strippoli
|
||
| 14:15 - 14:30 | Panel Discussion |
Mai-Szu Wu
Robert Walker
|
||
| 14:30 - 14:45 | Basic Research in Nephrology: Challenges and Opportunities |
Reiko Inagi
|
||
| 14:45 - 15:00 | Multi-omics Application in Nephrology |
Yi-Chun Tsai
|
||
| 15:00 - 15:15 | Epigenetics in Precision Medicine for Kidney Disease |
Yu-Hsiang Chou
|
||
| 15:15 - 15:30 | Panel Discussion |
Robert Walker
Chih-Wei Yang
|
||
| 15:30 - 15:35 | Closing Remark |
Chih-Wei Yang
|
- 【Invited Lecture I】
- Chair：Yi-Wen Chiu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 16:00 - 16:40 | Dialysis and the Heart: Unraveling Cardiovascular Complications |
Bengt Fellström
|
- 【Oral Presentation 5】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 10:30 - 12:00 | Oral Presentation |
- 【Luncheon Symposium 5】Sponsored by：Tai Tien Pharmaceuticals Co., Ltd.
- Chair：Ya-Chung Tian
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | Insights from Global Phase 3 Trials: Vadadustat in Anemia Treatment for CKD Patients on Dialysis |
Ya-Chung Tian
|
- 【Symposium 5】IgA Nephropathy: Past, Present, and Future
- Chair：Chiz-Tzung Chang、Tai-Shuan Lai
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 13:40 | Taiwan Kidney Biopsy Registry Report and Analysis |
Tai-Shuan Lai
|
||
| 13:40 - 14:00 | Current Knowledge of IgA Nephropathy: Epidemiology and Big Data Analysis |
Shang-Feng Tsai
|
||
| 14:00 - 14:20 | Understanding the Pathogenesis of IgA Nephrology |
Ann Chen
|
||
| 14:20 - 14:40 | Latest Developments of IgA Nephrology Clinical Trials |
Fan-Chi Chang
|
||
| 14:40 - 15:00 | Panel Discussion |
Tai-Shuan Lai
|
- 【MSN-NST-TSN Joint Symposium】Halting Diabetic Kidney Disease Progression to End-Stage Kidney Disease: From Policy to Implementation
- Chair：Yung-Ho Hsu, I-Wen Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 15:15 - 15:20 | Opening Remarks |
Yung-Ho Hsu
|
||
| 15:20 - 15:50 | MSN: Retard the Progression of DKD to ESKD: MyKidney Health 2030 |
Soo Kun Lim
|
||
| 15:50 - 16:20 | NST: The DKD Prevention Model in Thailand |
Vuddhidej Ophascharoensuk
|
||
| 16:20 - 16:50 | TSN: Perspectives on Implementation of Precision Medicine in DKD |
I-Wen Wu
|
||
| 16:50 - 17:00 | Panel Discussion and Closing Remarks |
- 【Oral Presentation 6】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 10:30 - 12:00 | Oral Presentation |
- 【Plenary Lecture】Professor Chen Wan-Yu Foundation Award
- Chair：Mai-Szu Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 08:30 - 09:10 | Big Data Approaches for Enhanced Precision Medicine in Kidney Disease |
Szu-Yuan Li
|
- 【Invited Lecture II】
- Chair：Mai-Szu Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 09:10 - 10:00 | The Latest Update on Treatment Options for IgA Nephropathy |
Adrian Liew
|
- 【KSN-TSN-JSDT Joint Symposium】Strategies to Reduce Burden of Diabetic Kidney Disease and End Stage Kidney Disease – A Local perspective
- Chair：Hyeong-Cheon Park、Tomonari Ogawa、Mai-Szu Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 10:00 - 10:05 | Opening Remarks |
Mai-Szu Wu
|
||
| 10:05 - 10:30 | KSN: Reducing The Incidence of Diabetic End-Stage Kidney Disease: Lesson from Korea Kidney Health Plan 2033 |
Sang Youb Han
|
||
| 10:30 - 10:55 | JSDT: Special Consideration of Dialysis Care for Diabetic End-Stage Kidney Disease Patients |
Katsuhito Mori
|
||
| 10:55 - 11:20 | TSN: Integrative Diabetes and Kidney Care – Taiwan Experience |
Chih-Cheng Hsu
|
||
| 11:20 - 11:30 | Panel Discussion and Closing Remarks |
- 【ISPD-TSN MOU】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 11:30 - 11:40 | Signing Ceremony |
- 【Luncheon Symposium 6】Sponsored by：Baxter
- Chair：Yung-Ho Hsu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | Role of Expanded Hemodialysis in Optimizing Dialysis Outcomes and Sustainable Healthcare Resourcing |
Patricia de Sequera
|
- 【Symposium 6】Overview of Vaccination for Kidney Patients
- Chair：Yung-Ho Hsu、Chien-Te Lee
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 14:00 | My Journey to Overcome Chronic Kidney Disease |
Naoki Kashihara
|
||
| 14:00 - 14:20 | Vaccination for CKD Patients |
Jiun-Chi Huang
|
||
| 14:20 - 14:40 | Vaccination for HD Patients |
Pei-Chen Wu
|
||
| 14:40 - 15:00 | Vaccination for Transplant Patients |
Mu-Chi Chung
|
- 【Symposium 7】The Results of 2023 Onsite Evaluation of Hemodialysis Centers
- Chair：Cheng-Jui Lin
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 15:00 - 15:05 | Opening |
Cheng-Jui Lin
|
||
| 15:05 - 15:25 | The Evaluation of Hemodialysis Centers: Taiwan versus Others |
Pei-Chen Wu
|
||
| 15:25 - 15:45 | The Results of Onsite Hemodialysis Evaluation [Chapters 1-2] |
Kai-Hsiang Shu
|
||
| 15:45 - 16:05 | The Results of Onsite Hemodialysis Evaluation [Chapters 4-6] |
Jian-Jhong Wang
|
||
| 16:05 - 16:25 | The Results of Onsite Hemodialysis Evaluation [Chapter 3] |
Tzu-Chun Chen
|
||
| 16:25 - 16:30 | Discussion |
- 【Luncheon Symposium 7】Sponsored by：GlaxoSmithKline Taiwan Branch
- Chair：Chih-Jen Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | A Shedding Light on Shingles Prevention for Patients with CKD |
Naoki Kashihara
|
- 【Symposium 8】Genetic Breakthroughs in the Battle Against CKD/ESKD
- Chair：Chien-Hsing Wu、Yu-Tzu Chang
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 14:00 | Genotype and Phenotype in Atypical Polycystic Kidney Disease Genes |
Daw-Yang Hwang
|
||
| 14:00 - 14:25 | Murine Models of Hereditary Renal Diseases |
Si-Tse Jiang
|
||
| 14:25 - 14:50 | Autosomal Recessive Renal Tubular Dysgenesis: From Bedside to Bench |
Min-Hua Tseng
|
||
| 14:50 - 15:00 | Discussion |
- 【Symposium 9】Cross-Disciplinary Approaches in Stem Cell Therapy
- Chair：Junne-Ming Sung、Po-Tsang Lee
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 15:00 - 15:30 | The Promise and Challenges of Allogenic Stem Cell-based Therapies |
Yen-Wen Liu
|
||
| 15:30 - 15:55 | High-resolution Characterization of Human Source-specific Mesenchymal Stem Cells for Therapeutic Use: "One Cell Source" does not fit all |
Betty Linju Yen
|
||
| 15:55 - 16:20 | Stem Cell-based Models for Hereditary Renal Disease |
Jia-Jung Lee
|
||
| 16:20 - 16:30 | Discussion |
- 【TCDA General Assembly】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 09:00 - 11:30 | TCDA General Assembly |
- 【Luncheon Symposium 8】Sponsored by：Novo Nordisk Taiwan
- Chair：Chia-Chao Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | Patient-Centered Approaches to Diabetes Management in CKD with Tresiba and Ryzodeg |
Wei-Hung Lin
|
- 【Symposium 10】Combat ESRD and Complication
- Chair：Jin-Shuen Chen、Shih-Yuan Hung
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 13:05 | Opening | |||
| 13:35 - 13:55 | Combat Kidney Disease: the Role and Responsibilities of the Nephrologist in the Medical Center |
Chih-Yu Yang
|
||
| 13:55 - 14:15 | Combat Kidney Disease: My Survival Path with the Diabetes Mellitus and CKD Care of Hemodialysis Clinic |
Guo-Liang Lu
|
||
| 14:15 - 14:35 | Interventional Nephrology : Permcath/PD Catheter Insertion |
Hsiu-Chien Yang
|
||
| 14:35 - 14:55 | Ultrasound in Dialysis Access |
Chung-Kuan Wu
|
||
| 14:55 - 15:00 | Closing |
- 【Symposium 11】PD Session
- Chair：Mai-Szu Wu、Chih-Yu Yang
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 15:00 - 15:05 | Opening Remark |
Mai-Szu Wu
|
||
| 15:05 - 15:40 | Why PD? Is PD Still Relevant as a Preferred Modality of Kidney Replacement Therapy? |
Adrian Liew
|
||
| 15:40 - 16:05 | Putting Transformation into Practice – A Smart Care Model of Peritoneal Dialysis |
Mu-Chi Chung
|
||
| 16:05 - 16:15 | Panel Discussion |
Chih-Yu Yang
|
||
| 16:15 - 16:20 | Closing |
- 【Invited Lecture III】
- Chair：I-Wen Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 10:30 - 11:10 | Gut Microbiota and Uremic Toxins - A Clue to the Human Health |
Takaaki Abe
|
- 【TSN General Assembly】
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 11:30 - 12:00 | TSN General Assembly |
- 【Luncheon Symposium 9】Sponsored by：DKSH Taiwan Ltd.
- Chair：Yu-Juei Hsu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 12:45 | Management of Secondary Hyperparathyroidism by Elvocalcet, from experiences in Japan |
Masahide Mizobuchi
|
||
| 12:45 - 13:10 | Elvocalcet: A New Calcimmetics Landing in Taiwan |
Jiann-Der Lee
|
- 【Symposium 12】Acute Kidney Injury: The Danger of Sudden Damage and Slow Recovery
- Chair：Ji-Tseng Fang、Te-Chao Fang
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 13:55 | The Role of Novel Antihyperglycemic Agents in Acute Kidney Injury to Chronic Kidney Disease (AKI-CKD) Transition |
Chun Yin See
|
||
| 13:55 - 14:20 | AI's Guardianship: Against the Journey of AKI to Terminal Kidney Disease |
Tsai-Jung Wang
|
||
| 14:20 - 14:45 | Team Care Management for Acute Kidney Disease and Intellectual Technology Application |
Chien-Hao Su
|
||
| 14:45 - 15:10 | Choice of Fluid for Patients with Acute Kidney Injury |
Yen-Ta Huang
|
- 【CKD education Course】Co-care of Chronic Kidney Disease, Cardiovascular and Cerebrovascular Disease
- Chair：Yi-Chun Tsai
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 09:00 - 09:30 | Atrial Fibrillation in Chronic Kidney Disease Treatment |
Shang-Feng Tsai
|
||
| 09:30 - 10:00 | Co-care of Heart Failure and Chronic Kidney Disease |
Wei-Hung Lin
|
||
| 10:00 - 10:30 | Current Status and Prospects of Stroke Treatment |
Shih-Hsuan Chen
|
||
| 10:30 - 10:40 | Discussion |
- 【CKD education Course】Kidney Health Promotion Institutions Forum
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 11:00 - 12:00 | Kidney Health Promotion Institutions Forum |
- 【Luncheon Symposium 10】Sponsored by：Everest Medicines (Singapore)Pte. Ltd.
- Chair：Yi-Wen Chiu、Cheng-Hsu Chen
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 13:10 | NEFECON – A Recently Approved Novel Disease Modifying Treatment of IgA Nephropathy |
Bengt Fellström
|
- 【Symposium 13】TWRDS: From History and Experience to Future Care
- Chair：Mai-Szu Wu、Chih-Cheng Hsu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 13:30 - 13:35 | Opening Remark |
Mei-Yi Wu
|
||
| 13:35 - 13:55 | Updated Taiwan End-stage Kidney Disease Trends |
Chih-Cheng Hsu
|
||
| 13:55 - 14:15 | Taiwan Kidney Disease Registry: Data, Platform, Work flow |
Shang-Jyh Hwang
|
||
| 14:15 - 14:35 | Erythropoietin and Mortality in Taiwan Dialysis Patients |
Szu-Yu Pan
|
||
| 14:35 - 14:55 | Current Status and Challenges of Peritoneal Dialysis Therapy in Taiwan |
Chih-Yu Yang
|
||
| 14:55 - 15:00 | Discussion and Closing Remark |
Mai-Szu Wu
|
- 【Luncheon Symposium 11】Sponsored by：Sanofi Taiwan Co., Ltd
- Chair：Mai-Szu Wu、Ming-Ju Wu
| Time (UTC+8) | Topic | Speaker | Abstract | |
|---|---|---|---|---|
| 12:20 - 12:25 | Opening | |||
| 12:25 - 12:35 | Local Nephrology Registry: Fabry patient with chronic kidney disease |
Tai-Shuan Lai
|
||
| 12:35 - 12:55 | Insights of Fabry disease: Expert consensus approach for screening, diagnosis, and multidisciplinary management in chronic kidney disease |
Cheng-Jui Lin
|
||
| 12:55 - 13:05 | Q&A | |||
| 13:05 - 13:10 | Closing remark |